Our data contribute to a better understanding of the role of the transcription factors, ΔNp63α and GLI2 in OS and suggest that the ΔNp63α-GLI2 axis may serve as a target for therapy of osteosarcoma. This evidence concerns the gene GLI2 and osteosarcoma.